Guilin Sanjin Pharmaceutical Co., Ltd. (002275.SZ)
CNY 14.75
(0.07%)
CNY 14.75
(0.07%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 549.24 Million | 528.66 Million | 410.24 Million | 597.99 Million | 468.28 Million | 551.72 Million |
| Net Income | 421.29 Million | 329.52 Million | 343.71 Million | 277.02 Million | 392.14 Million | 413.34 Million |
| Depreciation & Amortization | 115.11 Million | 114.83 Million | 106.71 Million | 80.26 Million | 90.68 Million | 75.71 Million |
| Deferred income taxes | -1.13 Million | 2.42 Million | -2.36 Million | 1.65 Million | 3.88 Million | 1.24 Million |
| Stock-based compensation | 30.47 Million | 65.77 Million | - | - | - | - |
| Change in working capital | -35.75 Million | 32.82 Million | -48.76 Million | 240.09 Million | -22.37 Million | 42.3 Million |
| Other non-cash items | 10.16 Million | -16.7 Million | 8.57 Million | 613.49 Thousand | 7.83 Million | 20.35 Million |
| Investing Cash Flow | -94.22 Million | -80.24 Million | -146.97 Million | -207.95 Million | -673.56 Million | 195.51 Million |
| Investments in PPE | -76.39 Million | -62.26 Million | -144.09 Million | -205.47 Million | -226.14 Million | -89.96 Million |
| Acquisitions | 53.69 Million | 2.75 Million | 27.72 Million | 7.2 Million | 1.44 Million | 92.48 Million |
| Investment purchases | -986.57 Million | -702.35 Million | -1.02 Billion | -1.35 Billion | -255.5 Million | -754.4 Million |
| Sales/Maturities of investments | 658.59 Million | 651.55 Million | 1.19 Billion | 1.07 Billion | 269.29 Million | 1.03 Billion |
| Other Investing Activities | 256.46 Million | 30.06 Million | -193.93 Million | 275.2 Million | -462.66 Million | -89.96 Million |
| Financing Cash Flow | -361.56 Million | -682.78 Million | -319.88 Million | -81.89 Million | -344.1 Million | -263.42 Million |
| Debt repayment | -77.11 Million | -295.6 Million | -154.4 Million | -104.27 Million | -100 Million | -100 Million |
| Dividends payments | -411.29 Million | -528.81 Million | -460.21 Million | -132.31 Million | -203.88 Million | -238.9 Million |
| Common Stock Repurchased | - | - | - | - | -179.48 Million | -24.51 Million |
| Common Stock Issuance | - | - | - | - | 179.48 Million | - |
| Other Financing Activities | -10.9 Million | 183.7 Million | 288.2 Million | 169.1 Million | -33.82 Million | 75.48 Million |
| Accounts receivables | 72.95 Million | -88.24 Million | -66.83 Million | 108.49 Million | 93.44 Million | -36.52 Million |
| Accounts payables | -80.34 Million | 84.97 Million | 120.15 Million | 148.36 Million | -91.69 Million | 27.24 Million |
| Inventory | -27.23 Million | 33.66 Million | -99.72 Million | -18.42 Million | -28 Million | 50.34 Million |
| Other working capital | 30.47 Million | 2.42 Million | -2.36 Million | 1.65 Million | 3.88 Million | -8.03 Million |
| Cash at beginning of period | 689.58 Million | 915.62 Million | 974.95 Million | 667.95 Million | 1.21 Billion | 733.51 Million |
| Cash at end of period | 783.9 Million | 689.58 Million | 915.62 Million | 974.95 Million | 667.95 Million | 1.21 Billion |
| Capital Expenditure | -76.39 Million | -62.26 Million | -144.09 Million | -205.47 Million | -226.14 Million | -89.96 Million |
| Effect of forex changes on cash | 864.97 Thousand | 8.31 Million | -2.71 Million | -1.12 Million | 33.68 | - |
| Net cash flow / Change in cash | 94.32 Million | -226.04 Million | -59.33 Million | 307 Million | -549.38 Million | 483.81 Million |
| Free Cash Flow | 472.85 Million | 466.4 Million | 266.15 Million | 392.51 Million | 242.14 Million | 461.76 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 82.9 Million | 200.95 Million | 100.01 Million | 421.29 Million | -6.14 Million | 17.35 Million |
| Depreciation & Amortization | - | 28.05 Million | 28.05 Million | 115.11 Million | 31.69 Million | -55.04 Million |
| Deferred income taxes | - | - | - | -1.13 Million | - | 268.36 Million |
| Stock-based compensation | - | 2.85 Million | - | 30.47 Million | 30.47 Million | -17.98 Million |
| Change in working capital | - | 61.15 Million | - | -35.75 Million | 76.2 Million | -175.61 Million |
| Other non-cash items | -34.57 Million | 70.22 Million | -73.46 Million | 10.16 Million | 6.14 Million | 3.62 Million |
| Investing Cash Flow | -49.64 Million | 244.63 Million | -116.4 Million | -94.22 Million | -15.56 Million | -85.13 Million |
| Investments in PPE | -35.54 Million | 7.37 Million | -9.78 Million | -76.39 Million | -28.05 Million | -32.88 Million |
| Acquisitions | -139.69 Thousand | -206.98 Thousand | 3.26 Million | 53.69 Million | 53.36 Million | 211.46 Thousand |
| Investment purchases | -154.41 Million | -52.22 Million | -141.35 Million | -986.57 Million | -698.45 Million | -162.05 Million |
| Sales/Maturities of investments | 101.83 Million | 263.02 Million | 99.73 Million | 658.59 Million | 404.85 Million | 69.85 Million |
| Other Investing Activities | 38.48 Million | 26.67 Million | -68.26 Million | 256.46 Million | 252.72 Million | 39.73 Million |
| Financing Cash Flow | 25.57 Million | -119.57 Million | -101.54 Million | -361.56 Million | -186.91 Million | -14.23 Million |
| Debt repayment | -25.05 Million | -63.58 Million | -85.62 Million | -77.11 Million | -47.78 Million | -45.88 Million |
| Dividends payments | - | -178.61 Million | -14.96 Million | -411.29 Million | -177.48 Million | -1.89 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 517.36 Thousand | -4.54 Million | -955.02 Thousand | -10.9 Million | -57.2 Million | 33.53 Million |
| Accounts receivables | - | 34.16 Million | - | 72.95 Million | 72.95 Million | -195.39 Million |
| Accounts payables | - | - | - | -80.34 Million | - | 27.92 Million |
| Inventory | - | 2.37 Million | - | -27.23 Million | -27.23 Million | 19.78 Million |
| Other working capital | - | 24.6 Million | - | 30.47 Million | 30.47 Million | -27.92 Million |
| Cash at beginning of period | 894.53 Million | 657.48 Million | 850.28 Million | 689.58 Million | 750.84 Million | 809.88 Million |
| Cash at end of period | 966.5 Million | 894.53 Million | 657.48 Million | 783.9 Million | 783.9 Million | 750.84 Million |
| Capital Expenditure | -35.54 Million | 7.37 Million | -9.78 Million | -76.39 Million | -28.05 Million | -32.88 Million |
| Effect of forex changes on cash | -805.45 Thousand | 98.22 Thousand | 98.3 Thousand | 864.97 Thousand | -600.1 Thousand | -366.32 Thousand |
| Net cash flow / Change in cash | 71.97 Million | 237.05 Million | -192.79 Million | 94.32 Million | 33.05 Million | -59.03 Million |
| Free Cash Flow | 12.78 Million | 250.5 Million | 16.76 Million | 472.85 Million | 278.98 Million | 7.81 Million |
GOODN
FIZZ
QIA
603588
WRAP
600770